4/9
07:42 am
kura
Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026 [Yahoo! Finance]
Low
Report
Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026 [Yahoo! Finance]
4/9
07:30 am
kura
Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026
Low
Report
Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026
4/3
07:30 am
kura
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/24
01:27 pm
kura
Kura Oncology (KURA) had its price target lowered by Mizuho from $30.00 to $25.00. They now have an "outperform" rating on the stock.
Low
Report
Kura Oncology (KURA) had its price target lowered by Mizuho from $30.00 to $25.00. They now have an "outperform" rating on the stock.
3/13
01:01 pm
kura
Kura Oncology (KURA) had its "buy" rating reaffirmed by UBS Group AG.
Low
Report
Kura Oncology (KURA) had its "buy" rating reaffirmed by UBS Group AG.
3/12
04:07 pm
kura
Kura Oncology, Inc. (KURA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Kura Oncology, Inc. (KURA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/8
08:34 am
kura
How The Kura Oncology (KURA) Story Is Shifting With Komzifti And New Street Targets [Yahoo! Finance]
Medium
Report
How The Kura Oncology (KURA) Story Is Shifting With Komzifti And New Street Targets [Yahoo! Finance]
3/6
08:55 am
kura
Kura Oncology (KURA) had its price target lowered by Wedbush from $38.00 to $36.00. They now have an "outperform" rating on the stock.
Medium
Report
Kura Oncology (KURA) had its price target lowered by Wedbush from $38.00 to $36.00. They now have an "outperform" rating on the stock.
3/6
07:30 am
kura
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/5
10:17 pm
kura
Kura Oncology Inc (KURA) Q4 2025 Earnings Call Highlights: KOMZIFTI Launch Boosts Revenue Amid ... [Yahoo! Finance]
Medium
Report
Kura Oncology Inc (KURA) Q4 2025 Earnings Call Highlights: KOMZIFTI Launch Boosts Revenue Amid ... [Yahoo! Finance]
3/5
09:23 pm
kura
Kura Oncology Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Kura Oncology Q4 Earnings Call Highlights [Yahoo! Finance]
3/5
12:56 pm
kura
Kura Oncology, Inc. (KURA) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Kura Oncology, Inc. (KURA) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/5
12:51 pm
kura
Kura Oncology, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Kura Oncology, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
3/5
06:57 am
kura
Kura Oncology: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
Kura Oncology: Q4 Earnings Snapshot [Yahoo! Finance]
3/5
06:42 am
kura
Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/5
06:31 am
kura
Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results
3/2
01:00 am
kura
Neutral
Report
2/28
05:57 am
kura
Kura Oncology (KURA) was upgraded by Zacks Research from "strong sell" to "hold".
Neutral
Report
Kura Oncology (KURA) was upgraded by Zacks Research from "strong sell" to "hold".
2/26
08:13 am
kura
Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
2/26
07:30 am
kura
Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results
2/25
08:03 am
kura
Kura Oncology to Participate in Three Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Kura Oncology to Participate in Three Upcoming Investor Conferences [Yahoo! Finance]
2/25
07:30 am
kura
Kura Oncology to Participate in Three Upcoming Investor Conferences
Low
Report
Kura Oncology to Participate in Three Upcoming Investor Conferences
2/22
02:02 am
kura
Low
Report
2/6
07:30 am
kura
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/2
09:44 am
kura
Analyst Flags Kura Oncology, Inc. (KURA) for 2026 Milestones and Pipeline Expansion [Yahoo! Finance]
Low
Report
Analyst Flags Kura Oncology, Inc. (KURA) for 2026 Milestones and Pipeline Expansion [Yahoo! Finance]